Literature DB >> 12761658

Haplotype analysis of the ETM2 locus in familial essential tremor.

Joseph J Higgins1, Joseph Jankovic, Roni Q Lombardi, Joanna Pucilowska, Eng King Tan, Tetsuo Ashizawa, Melanie U Ruszczyk.   

Abstract

The objective of this study was to analyze a sample of unrelated individuals with autosomal dominant essential tremor (ET) for a genetic association with loci in a candidate region (ETM2) on chromosome 2p24.1 that harbors a disease gene for ET. ET is a common movement disorder that is genetically linked to ETM2 in four large families. It is unknown whether this candidate locus is associated with dominantly inherited ET in other individuals. Based on information from previous genetic linkage studies, a linkage disequilibrium study was designed to compare individuals with a family history of ET (n=45) with normal controls (n=70). Three unreported dinucleotide polymorphic loci (etm1240, etm1231, and etm1234) were identified on a physical map of the ETM2 interval in a region of no recombination. The study sample was tested for allele frequency differences by the CLUMP program and haplotypes were analyzed by the FASTEHPLUS program. The allele frequencies were significantly different between ET cases and the control samples for the loci etm1231 (P< or =0.0419) and etm1234 (P<0.0001). A haplotype formed by the loci etm1231 and etm1234 occurred with a frequency of 29% in cases (n=45) and 9% in a white newborn sample (P<0.0001, n=35). The haplotype was not found in normal individuals older than 60 years without tremor (P=0.0063, n=35). This study provides evidence that an ancestral haplotype on chromosome 2p24.1 segregates with the ET disease phenotype in individuals with a family history of the disorder and will facilitate the search for a causative gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761658     DOI: 10.1007/s10048-003-0151-2

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  20 in total

1.  A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor.

Authors:  M Farrer; K Gwinn-Hardy; M Muenter; F W DeVrieze; R Crook; J Perez-Tur; S Lincoln; D Maraganore; C Adler; S Newman; K MacElwee; P McCarthy; C Miller; C Waters; J Hardy
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

Review 2.  How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world.

Authors:  E D Louis; R Ottman; W A Hauser
Journal:  Mov Disord       Date:  1998-01       Impact factor: 10.338

Review 3.  Essential tremor: clinical characteristics.

Authors:  J Jankovic
Journal:  Neurology       Date:  2000       Impact factor: 9.910

4.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci.

Authors:  P C Sham; D Curtis
Journal:  Ann Hum Genet       Date:  1995-01       Impact factor: 1.670

5.  A study of hereditary essential tremor.

Authors:  P G Bain; L J Findley; P D Thompson; M A Gresty; J C Rothwell; A E Harding; C D Marsden
Journal:  Brain       Date:  1994-08       Impact factor: 13.501

6.  [Essential tremor: phenomenology and epidemiology (author's transl)].

Authors:  F Gerstenbrand; D Klingler; B Pfeiffer
Journal:  Nervenarzt       Date:  1982-01       Impact factor: 1.214

7.  Mapping of a familial essential tremor gene, FET1, to chromosome 3q13.

Authors:  J R Gulcher; P Jónsson; A Kong; K Kristjánsson; M L Frigge; A Kárason; I E Einarsdóttir; H Stefánsson; A S Einarsdóttir; S Sigurthoardóttir; S Baldursson; S Björnsdóttir; S M Hrafnkelsdóttir; F Jakobsson; J Benedickz; K Stefánsson
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

8.  A gene (ETM) for essential tremor maps to chromosome 2p22-p25.

Authors:  J J Higgins; L T Pho; L E Nee
Journal:  Mov Disord       Date:  1997-11       Impact factor: 10.338

9.  Genotypes of alcohol-metabolizing enzymes in Japanese with alcohol liver diseases: a strong association of the usual Caucasian-type aldehyde dehydrogenase gene (ALDH1(2)) with the disease.

Authors:  A Shibuya; A Yoshida
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

10.  Essential tremor: clinical correlates in 350 patients.

Authors:  J S Lou; J Jankovic
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

View more
  6 in total

Review 1.  'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-12-03       Impact factor: 3.282

2.  A variant in the HS1-BP3 gene is associated with familial essential tremor.

Authors:  J J Higgins; R Q Lombardi; J Pucilowska; J Jankovic; E K Tan; J P Rooney
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

3.  The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.

Authors:  Maria C Ledesma; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Félix Javier Jiménez-Jiménez; Julián Benito-León; Inmaculada Puertas; Lluisa Rubio; Tomás López-Alburquerque; José A G Agúndez
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

Review 4.  Environmental epidemiology of essential tremor.

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

Review 5.  Genomic Markers for Essential Tremor.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; Ignacio Álvarez; Pau Pastor; José A G Agúndez
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

6.  Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor.

Authors:  Carmen Martínez; Elena García-Martín; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Julián Benito-León; Isabel García-Ferrer; Pilar Vázquez-Torres; Inmaculada Puertas; José M Zurdo; Tomás López-Alburquerque; José A G Agúndez
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 4.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.